Comparison of the Effects of different doses Sufentanil and Dexmedetomidine on Prevention of Emergence Agition in Children undergoing Tonsillectomy and Adenoidectomy Sugery

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IIR-17010413

Enrollment

Unknown

Registered

2017-01-13

Start date

2017-01-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tonsil and Adenoid hypertrophy

Interventions

control group:null

Dexmedetomidine goup:0.4 ug/kg/h from induction of anesthesia until 10 min

Dexmedetomidine plus sufentanil 0.1 ug/kg:0.4 ug/kg/h from induction of anesthesia until 10 min plus sufentanil 0.1 ug/kg

Dexmedetomidine plus sufentanil 0.2 ug/kg:0.4 ug/kg/h from induction of anesthesia until 10 min plus sufentanil 0.2 ug/kg

Eligibility

Sex/Gender

All

Age

3 Years to 7 Years

Inclusion criteria

Inclusion criteria: aged between 3 and 7 years with an ASA physical status I or II, who were scheduled for either an adenoidectomy alone or both an adenoidectomy and tonsillectomy

Exclusion criteria

Exclusion criteria: Patients with cardiac disease, developmental delay,abnormal upper airway, asthma, or a history of upper respiratory tract infection in the preceding 4 weeks were excluded.

Design outcomes

Primary

Measure	Time frame
heart rate;mean arterial pressure;pediatric anesthesia emergence delirium;incidence of EA;Time to extubation;Time to awake;	—

Countries

China

Contacts

Public ContactYanzhuo Zhang

Department of Anesthesiology, the Second Affiliated Hospital of Harbin Medical University

zhangyanzhuo625@sina.com+86 17745126625

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026